Scientists shut off the dopamine in some rats and they stopped eating. Food everywhere. They starved in a full cage, not because they hated it. Put sugar on their tongue and they licked their lips. They still liked it. They just lost the drive to go get it.
This is one of the strangest things we know about the brain, and it traces back to a researcher named Kent Berridge at the University of Michigan. Your head runs two different systems. One is wanting, the push that gets you off the couch and moving. The other is liking, the good feeling once you are in it. Dopamine runs the wanting. The enjoyment runs on separate wiring. So you can be sure you will love something and still feel almost no pull to start it.
That is the man in the cartoon, swinging at rock with diamonds all around him. He could see the good stuff. He just could not make himself dig toward it.
Once you see why, the usual story about procrastination stops making sense. We say lazy, or bad with time. Mostly, it is neither. Two psychologists, Fuschia Sirois and Tim Pychyl, argued back in 2013 that it runs on emotion. A task makes you feel something you would rather not feel, even just the small dread of starting, and putting it off makes that feeling vanish on the spot. So you scroll, or you suddenly need to clean the kitchen. Dodging the task is a quick hit of relief, and your brain grabs it. The bill goes straight to future-you, who is left holding the guilt and the deadline.
You can even see it on a brain scan. In 2018, a team in Germany scanned 264 people and matched the scans against how much each person put things off. The big procrastinators had a larger amygdala, the little alarm bell deep in the brain that flags anything risky. They also had a weaker link to the part meant to quiet that alarm and get you moving, a region called the dorsal anterior cingulate cortex. Loud alarm, weak off-switch.
And if this is you, you have plenty of company. A big 2007 review found that 80 to 95 percent of college students procrastinate, that roughly one in five adults does it long-term, and that more than 95 percent of them wish they could quit. Students alone burn about a third of their day on it.
The fix falls out of that same split. If wanting and liking are two different systems, then waiting to "feel like it" is waiting for a bus that may never come. The main treatment for the severe version, called behavioral activation, flips the order. You start first, as small as you can stand, before any motivation shows up. The wanting tends to arrive a few minutes after you begin. The diamonds were there the whole time. You just have to swing the pick before you feel ready.
Part 2. Brain scanners caught something strange about the word "later." When you picture future-you, the one who will finally read the book or take the trip, your brain treats that person like a stranger it has never met. So you hand the good stuff to them, and they never show up.
Hal Hershfield slid people into a scanner and had them think about who they are now, about a stranger, and about who they will be years down the line. The future version lit up the way a stranger does. And the wider that gap ran, the more a person grabbed a small reward now over a much bigger one later. In a follow-up, just showing people an aged photo of their own face, wrinkles and all, nudged them into setting aside more money for that distant self. To your brain, later belongs to someone else.
There is a second trap on top of that. In one set of studies, people chose between a task with a tight deadline and a task worth far more with a looser one, and they kept grabbing the urgent one, even when it paid less. The researchers called it the mere urgency effect. Anything with a ticking clock jumps the line, however little it is worth. And fun almost never comes with a deadline. The book on the shelf, the trip you keep putting off, they make no noise at all, so they lose to whatever is beeping.
That is the whole cartoon. The man hammers at the urgent rock in front of him while the diamonds sit there, worth a fortune, going nowhere, waiting on a version of him who keeps not showing up.
The fix is almost stupidly small. Vague plans lose to urgency and to the stranger. Specific ones hold. Across more than 90 studies and 8,000 people, the ones who pinned down an exact when and where followed through far more often than the ones who just meant to get to it. As in: if it is Saturday at 9, then I open the book. Give the fun a slot, the way you would a dentist appointment. Future-you needs a calendar invite, because future-you is a stranger, and strangers do not show up unless you book them.
Part 3. A fancy grocery store set out 24 jams to taste. Crowds stopped to try them. Almost nobody bought a jar. Another day the same store put out just 6 jams instead, and sales jumped about tenfold. Same jams, same shop. The only thing that changed was how many choices people had.
The jam study is famous, and it is shakier than its fame. When other researchers tried to repeat it, the effect often vanished. But in 2015 a team pooled about 100 of these experiments and pinned down exactly when it bites. Too much choice freezes you when the options are many and look alike and you are not sure what you want in the first place. Add in that you mostly just want the decision made, and you get paralysis. Which is a fair description of opening a streaming app at 9pm.
Money on the line does the same thing. When researchers looked at the retirement savings of nearly 800,000 workers, the plans that offered more fund options had fewer people signing up at all. People walked away from free money their employer would have matched, thousands of dollars of it, because picking felt like too much. Sign-ups were highest when there were only about three funds to weigh.
Psychologists call the freeze choice deferral. Faced with a pile of good options, you make the easiest move available, which is no move, and you reach for the one thing that asks nothing of you. The feed. It gets worse if you are the type who hunts for the best option rather than a good one. Across seven studies, the people who chase the single best choice tend to end up less happy and more prone to regret than the ones who grab the first thing that is good enough.
That is the cartoon, one more way. The guy stands in a field of diamonds, every one worth grabbing, and he freezes trying to find the very best one. So he picks none and stays put. The fix is to shrink the menu and lower the bar on purpose. Pick three things you would enjoy tonight, not thirty. Then start the first one that clears the bar, instead of holding out for the perfect one. Chasing the best possible evening is the exact thing that eats the evening.
Sources for part 3:
Iyengar and Lepper 2000, When Choice is Demotivating, Journal of Personality and Social Psychology, the jam study with 24 versus 6 options courses.lumenlearning.com/waymaker-psych…
Choice overload meta-analysis, Chernev Bockenholt and Goodman 2015, Journal of Consumer Psychology, 99 observations, the four conditions that trigger overload chernev.com/wp-content/upl…
Iyengar Huberman and Jiang 2004, How Much Choice is Too Much, 401k participation across nearly 800,000 employees falls as fund options rise repository.upenn.edu/items/cdc2d4cd…
Schwartz and colleagues 2002, Maximizing versus Satisficing, maximizers report more regret and less satisfaction than satisficers pubmed.ncbi.nlm.nih.gov/12416921/
Part 4. Researchers put people in a bare room for 15 minutes with nothing to do but think. First they had everyone try a mild electric shock, and most said they would pay money to never feel it again. Then they left them alone with the shock button. Two thirds of the men pressed it. One man pressed it 190 times. A quarter of the women did it too, choosing a jolt of pain over sitting quietly with their own minds.
The team, led by Timothy Wilson at the University of Virginia, ran eleven versions and kept landing in the same place. Sitting still and fully unplugged is one of the most uncomfortable things a person can do. The quiet itself is what stings. People rated reading or listening to music about twice as enjoyable as just thinking.
Now look at the things you keep meaning to enjoy: reading a novel, a long walk, picking up an instrument, an hour of doing nothing in particular. Every one of them opens with a flat, quiet stretch where not much is happening and it is only you and the thing. The phone offers the exact opposite, instantly and for free. So you grab the bright, frictionless thing and bounce right off the calm one you said you wanted.
Boredom is what you feel in that flat stretch. It is the restless itch to engage when nothing around you will hold your attention, a hungry hunting state in which you grab the nearest handhold. The phone is always in reach. That itch usually breaks fast if you let it. In one study, people made to copy numbers out of a phone book, about as dull as it gets, came out more creative on the next task than people who skipped the boring part. The boredom was the on-ramp to the good part.
So the move is almost the opposite of trying harder. When the urge to grab the phone hits, do nothing for a beat and let the flat feeling sit there. It passes in a couple of minutes, and the calmer thing becomes reachable. Then take away the easy exit. Put the phone in another room, far enough that you would have to get up to reach it. In the cartoon, the diamonds wrap all the way around a dark, silent tunnel. The quiet is the door to them. You just have to be willing to stand in it for a minute.
Sources for part 4:
Wilson and colleagues 2014, Just think, the challenges of the disengaged mind, Science, the electric-shock study across 11 experiments dtg.sites.fas.harvard.edu/WILSON%20ET%20…
Wilson 2014 shock study, Science news summary, 67 percent of men and 25 percent of women shocked themselves, reading and music rated about twice as enjoyable as thinking science.org/content/articl…
Eastwood and colleagues 2012, The Unengaged Mind, boredom as the aversive experience of wanting but being unable to engage, Perspectives on Psychological Science pubmed.ncbi.nlm.nih.gov/26168505/
Mann and Cadman 2014, Does Being Bored Make Us More Creative, boring tasks raised creativity on the next task, Creativity Research Journal tandfonline.com/doi/abs/10.108…
Part 5. Researchers asked a group of students when they would finish their thesis. Each gave a date. Then they gave a second date, the worst case, if everything that could go wrong did. On average, the students finished later than their own worst-case guess. Only about a third hit the date they first predicted.
This is the planning fallacy, and it runs deeper than simple ignorance. The same students, asked how long their past projects had taken, gave longer, more honest numbers. They knew their own history. They just believed this time would be different. People can see the past clearly and still walk straight back into it.
Now zoom out from one task to your whole life. You would never look at your bank balance and assume that next month, for no reason, more money will appear. But almost everyone looks at the month ahead and quietly assumes it will be lighter than this one. In seven experiments, people expected far more spare time in the future than spare money. Money stays steady and you know it. Time feels different, because each day’s chaos wears a different outfit, so you never notice that the total barely moves.
Which is why the good stuff keeps getting parked in a future that never pulls in. The trip you keep not booking, the friend you keep meaning to see, all of it waits for a calmer stretch that the data says is a mirage. The miner in the cartoon is sure he will grab the diamonds during the next lull. The lull never comes.
The fix is almost mechanical, and it has held up in the lab. Stop predicting from the week you are imagining, which is always sunny and wide open. Look instead at the last four weeks you just lived through. They were full. Next week will be full in its own way too. So take the thing you keep deferring and put it on a specific day this week, not in the soft fog of soon. When researchers had people tie their plans to how things had truly gone before, the rosy forecasts collapsed into accurate ones.
The calm you are waiting for is not in the mail. The only week you are ever handed is this one.
Sources for part 5:
Buehler, Griffin and Ross 1994, Exploring the planning fallacy, why people underestimate their task completion times, Journal of Personality and Social Psychology, the thesis-prediction study and Study 4 outside-view fix
<bear.warrington.ufl.edu/brenner/mar758…>
Planning fallacy summary, the thesis numbers (33.9 days predicted, 48.6 worst case, 55.5 actual, about 30 percent on time) and the inside view versus outside view
<thedecisionlab.com/biases/plannin…>
Zauberman and Lynch 2005, Resource Slack and Propensity to Discount Delayed Investments of Time Versus Money, people expect more time slack in the future than money slack, Journal of Experimental Psychology General
<pubmed.ncbi.nlm.nih.gov/15702961/>
Why we overcommit, plain-language summary of Zauberman and Lynch, we assume more time ahead because daily demands vary while money needs stay predictable
<sciencedaily.com/releases/2005/…>
Part 6. Researchers had people log what they were doing, hour by hour, for days. Then they sorted it. Close to half of everything people did was habit, the same action in the same place, with no decision behind it. While they did it, their minds were off somewhere else entirely.
A habit is an action your brain has handed to autopilot. A cue shows up, you sit down on the couch, you reach for your phone, and the behavior runs itself from start to finish while you think about something unrelated. These scripts are hard to shake. They keep you doing what you have always done, even on the days you fully meant to do otherwise.
The enjoyable things are almost never on autopilot. Reading the book, calling the friend, getting the guitar down off the shelf, none of it is a grooved script. Each one asks you to stop, decide, and break the routine already running. So every day the good thing goes up against your autopilot, and autopilot never gets tired and never needs convincing. The fun thing loses by default, every single day, just by never making it onto the automatic list.
Look at the miner in the cartoon. His swing is pure rote, the same arc into the same rock, and the diamonds sit just off the path his autopilot keeps carving. Turning would mean breaking stride, and breaking stride is the one thing a groove will not do on its own.
So the way out is to stop treating the enjoyable thing as a fresh decision every time and turn it into a script of its own. Pick one slot, the same time and the same place, and run it there again and again until your brain quietly takes it over. It is slower than it sounds. People who tried this with a new daily behavior took about two months on average before it felt automatic, and some took far longer. The engine was plain repetition. Motivation hardly mattered. Missing a single day did not undo the progress.
You did not decide your way into the routine you have now. You will not decide your way into a better one either. You groove it in, one repeat at a time, until the book starts running itself the way the phone already does.
Sources for part 6:
Wood, Quinn and Kashy 2002, Habits in everyday life, two hourly-diary studies found 35 percent then 43 percent of behavior was habitual, between a third and a half, Journal of Personality and Social Psychology researchgate.net/publication/10…
Neal, Wood and Quinn 2006, Habits a repeat performance, habits fire automatically from context cues and run to completion with minimal conscious control, Current Directions in Psychological Science journals.sagepub.com/doi/abs/10.111…
Lally and colleagues 2010, How are habits formed, median 66 days to reach automaticity, range 18 to 254, repetition in a consistent context, missing one day did not derail it, European Journal of Social Psychology onlinelibrary.wiley.com/doi/abs/10.100…
Plain-language summary of the Lally habit-formation study, the 66-day average and that one missed day does not undo the progress bps.org.uk/research-diges…
Part 7. Researchers had people listen to a song they liked. First they got half of them to work out what an hour of their time was worth in money. That half enjoyed the song less, and spent most of it impatient for it to end. In another version of the study, the researchers paid people for the time they spent listening, and the enjoyment came back.
The song never changed. What changed was how the time felt. Once an hour got tagged as unpaid, unproductive time, the pleasure quietly drained out of it. Pay people for that same hour and the guilt lifts, because now the time is earning its keep.
Most of us run a faint version of that meter all day long. Some part of you treats a free hour as time you ought to be spending on something more useful. So the enjoyable thing, the book, the slow morning, the afternoon with nothing in it, sits under a low hum of guilt, as if you have not earned it yet. And the pile of things you are supposed to finish first never clears.
The culture leans on the scale, too. Being slammed has turned into a brag. Telling people you have no time, that the week is insane, now reads as proof that you matter and are in demand. A hundred years ago the flex was the exact opposite, endless leisure and nowhere you had to be. Against that backdrop, resting can feel like admitting you are not important enough to be busy.
So people reach for the obvious workaround. They make the fun productive. Read to improve yourself, take up a hobby that might pay off one day, file the rest under recovery so you can work harder later. When researchers tested that move, it did not work. Calling the leisure productive did nothing to bring the enjoyment back. The only kind of leisure that took the hit in the first place was the kind done purely for its own sake.
Look at the miner again. He is standing in a wall of diamonds, telling himself he will stop and pick one up once the shift is done. The shift is never done. So he keeps swinging at the plain rock, surrounded by the exact thing he is too busy to reach.
The way out is closer to a permission slip than a plan. There is no version of the list where you finally clear it and earn the afternoon, so the enjoyable thing has to happen inside an unfinished life or it does not happen at all. Stop pricing your own free hours. And do not dress the fun up as useful to make it feel allowed. Let it be pointless. You were never meant to earn it.
Sources for part 7:
DeVoe and House 2012, Time money and happiness, pricing time as an hourly wage made people more impatient and less able to enjoy a song, and paying them for the listening time restored the enjoyment, Journal of Experimental Social Psychology www-2.rotman.utoronto.ca/facbios/file/D…
Tonietto, Malkoc, Reczek and Norton 2021, Viewing leisure as wasteful undermines enjoyment, the belief lowers enjoyment of leisure and tracks with more depression, anxiety and stress, and framing leisure as productive does not restore it, Journal of Experimental Social Psychology papers.ssrn.com/sol3/papers.cf…
Bellezza, Paharia and Keinan 2017, Conspicuous consumption of time, a busy and overworked life has become an aspirational status symbol where leisure once was, Journal of Consumer Research academic.oup.com/jcr/article-ab…
Plain-language summary of the leisure-as-wasteful research, including that fun done purely for its own sake takes the biggest hit sciencedaily.com/releases/2021/…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Finnish scientists trucked in real forest dirt and grass and laid it over the gravel at four daycare yards. They let the kids dig around in it for a month. The blood tests came back with changes the researchers hadn’t expected to see so fast or so clear.
The study ran at ten daycares in two Finnish cities with 75 kids aged three to five. Four of the yards got the forest treatment: about a tennis court worth of soil and grass laid over the gravel, plus planters and peat blocks the kids could dig and climb on. Three others stuck with their normal gravel yards. The last three were daycares where the kids were already visiting real forests every day.
After one month, the variety of bacteria living on the kids’ skin shot up, and the kind that helps train the skin’s immune defenses jumped the most. Their gut bacteria started to look like the gut bacteria of the forest-visiting kids. Their blood showed more of the immune cells whose job is to keep the body from freaking out at harmless stuff like pollen and peanuts, and overall inflammation dropped. The kids on the plain gravel yards showed none of this.
Childhood asthma in the US doubled between 1980 and 1995. Food allergies in kids jumped 50 percent between 1997 and 2011, then jumped another 50 percent between 2007 and 2021. And peanut allergies in one-year-olds tripled between 2001 and 2017.
The Finnish researchers think one of the reasons is simple: kids today don’t get dirty enough. 37 percent of American preschoolers now spend an hour or less outside on a normal weekday. Their immune systems are getting trained in environments stripped of the bacteria humans have always lived around.
Aki Sinkkonen, who led the study, put it in plain words: “It would be best if children could play in puddles and everyone could dig organic soil.” The Finnish government is now helping pay for daycares across the country to make the same changes.
Follow @anishmoonka for daily stories across science, history, psychology, culture & AI.
—————
Sources:
Primary study: Roslund et al. 2020, Science Advances - Biodiversity intervention enhances immune regulation and health-associated commensal microbiota among daycare children science.org/doi/10.1126/sc…
AAAS news coverage of the study with lead researcher quotes from Marja Roslund and Aki Sinkkonen aaas.org/news/city-day-…
CDC National Survey of Children's Health 2021 - 37 percent of US preschoolers spend an hour or less outside on weekdays pubmed.ncbi.nlm.nih.gov/38128675/
Part 2. For nearly twenty years, doctors warned parents to keep peanuts away from young children. The advice was meant to prevent peanut allergies. It did the opposite. A 2015 trial finally tested what happens when babies eat peanut early instead. The allergy rate dropped 80 percent.
The trial that proved it was called LEAP. Gideon Lack and his team at King's College London enrolled 640 UK babies who were already at high risk for peanut allergy because they had severe eczema or an egg allergy. Half were assigned to eat peanut snacks three times a week from infancy. The other half avoided peanuts entirely for the next five years.
At age 5, 17 percent of the avoidance group had developed a peanut allergy. Only 3 percent of the eating group had. The trial appeared in the New England Journal of Medicine in February 2015 and immediately upended the official advice.
Lack's team had a theory for why early exposure works. Babies with eczema have damaged skin barriers. When peanut dust from the house lands on cracked skin, the immune system flags it as an enemy. But if the baby eats peanut first, the immune system learns to treat it as food.
In 2017, the National Institute of Allergy and Infectious Diseases issued new guidelines: start introducing peanut at 4 to 6 months for at-risk babies. The same approach now applies to other allergens like egg and milk. A whole generation of advice turned out to be backwards.
A male bee mates for less than 5 seconds in midair. The ejaculation is so explosive you can hear it pop from a few feet away. His body rips in half. He falls dead before hitting the ground. And he is one of the lucky males in the hive.
When a male bee, called a drone, chases down a queen mid-flight at speeds of 22 miles per hour, his entire reproductive organ turns inside out. The pressure required for this comes from nearly all the blood in his body, which rushes downward to force the organ outward like a spring. The semen fires into the queen with so much force it makes the audible pop. The organ then snaps off and stays lodged inside her like a cork. As he flips backward off her body, his abdomen rips open. The next drone waiting his turn has to physically yank out the dead male's cork before he can mate. The same thing then happens to him.
The queen does this 12 to 20 times in a single afternoon. She flies up to a spot in the sky that beekeepers call a drone congregation area. Picture an invisible meeting point about 50 to 130 feet above the ground where up to 11,000 male bees from as many as 240 different hives are hovering, waiting for her. These spots stay in the exact same locations year after year, sometimes for over a decade. No one fully understands how brand new drones, born only weeks earlier, find them.
By the end of her mating run, the queen has collected around 100 million sperm cells. She keeps only 5 to 6 million in a tiny internal storage organ that keeps them alive for years. From that supply, she uses just two sperm cells per egg for the rest of her life, laying up to 2,000 eggs a day for 2 to 7 years. After that one afternoon in the sky, she will never mate again.
A 2019 study from UC Riverside, the University of Copenhagen, and the University of Western Australia found that bee semen contains toxic proteins that temporarily blind the queen by interfering with how vision genes function in her brain. If she can't see well, she can't fly out again to mate with more males. Their semen also carries a separate protein that attacks and kills sperm cells from rival drones still inside her. The males keep competing long after every one of them is dead.
The 99.9% of drones who never get to mate have it worse. As autumn arrives, the female worker bees in the hive stop feeding their brothers, then drag them out of the entrance after biting off their wings. The drones can't fly back in. They starve or freeze in the grass within days. The colony raises a fresh batch of disposable males the next spring, and the whole cycle starts over.
Part 2. When a baby queen bee chews her way out of her cell, the very first thing she does is hunt down her sleeping sisters and sting them to death, one by one, often before they have even hatched. She is less than a day old. This is how every queen in every honeybee hive on Earth begins her life.
The queen and every worker bee in her hive share the exact same DNA. They are genetic twins. The only thing that turns one fertilized egg into a queen and another into a worker is what the baby gets fed in its first few days of life. Larvae chosen for the throne are flooded with royal jelly, a milky substance secreted from glands in the heads of nurse bees. It contains a fatty acid (10-HDA) that flips chemical switches inside the larva's cells, turning on a different set of genes without changing the underlying DNA. This entire field of biology, where diet rewires which genes activate, exists partly because scientists were trying to figure out how honeybees pull this off.
A queen develops in just 16 days, faster than any other bee in the hive. She emerges with a smooth, curved stinger built specifically for killing other queens. Workers have barbed stingers that rip out and kill them after one sting. The queen's stinger is reusable. She walks the comb making a high-pitched piping sound that beekeepers can actually hear with their ear pressed to a hive. Her unhatched sisters, still trapped in their wax cells, pipe back. She uses the sound to find them, slices a hole in the side of each cell, and stings them through the wall.
Once she has killed everyone, she flies out once in her life to mate. Then she returns to the hive and never leaves it again for 2 to 5 years. She lays up to 2,000 eggs a day, more than her own body weight every 24 hours, sometimes over a million eggs total in her lifetime. The whole time, she leaks scent chemicals from glands in her face that drift through the hive on the bodies of workers grooming her. Those chemicals chemically castrate her daughters, shutting down their ovaries so they cannot lay eggs of their own. The worker bees around her live just 6 weeks in summer. She lives 20 to 40 times longer.
She is not actually in charge of anything. The workers run the colony. The moment her egg-laying drops or her scent chemicals weaken (which happens if she gets infected with a virus or simply ages), the workers vote her out. They start building emergency queen cells, raise replacements, then murder her. The execution method is called "balling." 15 to 50 worker bees pile on top of her in a tight ball and use their own body heat to cook her alive from the inside. In commercial American beehives, over half of queens get replaced within 6 months. The mother of the entire colony is disposable the second she stops producing.
The new queen then chews her way out, kills her sisters, mates once, and the cycle starts again. A honeybee colony is not really ruled by a queen at all. It is a 50,000-female democracy that grows its own monarchs the way humans grow vegetables, then composts them when they wilt.
Oxygen already killed most of the life on Earth once. The first time it filled the air, around 2.4 billion years ago, it was so poisonous that nearly everything alive died. Scientists call it the Oxygen Catastrophe.
Back then the oceans were full of tiny microbes, and none of them used oxygen. Then one kind, an ancestor of the green scum you still see on ponds, started giving off oxygen as a waste gas, the same way you breathe out air you don’t need. Oxygen is a wrecker. It rips apart the delicate machinery inside a living cell, including the DNA, and as it built up in the water and then the sky, it triggered the first mass extinction this planet had ever seen.
A few survivors hid in the mud and deep underground where the gas couldn’t reach, and some of their descendants are still down there. But one tiny cell did something nobody else did. It ate a bacterium that had learned to use oxygen rather than die from it, and instead of digesting its meal, it kept it alive inside itself. That trapped bacterium became the mitochondria, the little engines that power your cells right now. Almost every cell you are made of carries hundreds or thousands of them, all descended from that one strange truce with a poison.
The trade was worth it because burning food with oxygen releases about 18 times more energy than burning it without. It is the reason anything can swim fast or think hard. Every big, fast-moving animal on Earth, you included, runs on the gas that almost ended life.
Oxygen changed the sky too. Some of it floated up high and turned into ozone, a thin layer that blocks most of the sun’s harshest rays. Before that shield existed, raw sunlight was strong enough to fry the DNA of anything out in the open, so life had to stay underwater, where a few feet of sea soaked up the danger. For almost two billion years, nothing lived on land at all. Only once the ozone grew thick enough, a few hundred million years ago, did the first plants and animals crawl out of the water.
And the old poison never really left. Every second, the oxygen your cells burn throws off tiny broken bits called free radicals, and they keep nicking your DNA and the proteins around it. The damage adds up, slowly, your whole life. Back in 1956 a scientist named Denham Harman suggested this slow rusting from the inside is a big reason we get old. People still argue about how much it matters, and no antioxidant pill has ever been shown to make anyone live longer, but the basic idea has held up. The gas keeping you alive right now is also quietly wearing you down, year by year. The joke just got the timing wrong. Oxygen really does kill slowly, and billions of years before we showed up, it already proved it can kill fast.
Part 2. Every time you hold your breath, the thing that finally forces you to gasp is carbon dioxide piling up in your blood, the same waste gas you breathe out. Your body watches that gas like a hawk. The oxygen you actually need to stay alive, it barely tracks at all, and that blind spot quietly kills strong swimmers every year.
The control sits in your brainstem, at the base of your skull, in a patch that runs your breathing without you ever thinking about it. It is constantly measuring carbon dioxide, and when the level creeps up even a little, it pushes you to breathe harder to clear the excess. A tiny rise in that one gas causes a big jump in how hard you breathe. Oxygen gets its own sensors, tucked into the big arteries in your neck, but they stay quiet until oxygen drops to dangerous levels, and even then their warning is faint next to the carbon dioxide alarm.
This is why holding your breath feels the way it does. That growing pressure in your chest near the end is the carbon dioxide alarm getting louder until you cannot hold out. Free divers train this exact feeling, learning to stay calm while the gas climbs, which is how some of them stay under for minutes on a single breath.
The blind spot turns deadly when people mute the alarm on purpose. Take a few fast, deep breaths before going underwater and you flush out so much carbon dioxide that the urge to breathe stays switched off far longer than it should. The trap is that clearing carbon dioxide does almost nothing for your oxygen. So a swimmer can glide along feeling fine while oxygen drains away, then black out with no warning. Water-safety groups call it shallow water blackout, and it is one of the quiet killers of fit, capable swimmers.
The same gap shows up far from any pool. Pilots who lose cabin pressure often feel no alarm as the oxygen thins, just a warm, slightly drunk calm while their judgment falls apart, which is why flight crews sit in low-oxygen chambers during training to learn what their own oxygen starvation feels like before it can fool them in the air. In sealed tanks and grain silos where the air has been pushed out by another gas, people can pass out after a few breaths without ever feeling short of air, because no carbon dioxide is building up to trip the alarm. Low oxygen can kill you, which is the exact fear in the joke. Your body just spends far more effort warning you about the gas you breathe out than the one you would die without.
Mark Cuban sold his company to Yahoo for $5.7 billion in 1999. Overnight, he was a billionaire. There was just one problem: Yahoo paid him in its own stock, he was banned from selling it for six months, and that stock was sitting on a bubble that was about to pop.
So he was a billionaire who couldn't actually reach his money. He owned 14.6 million shares of Yahoo, worth around $1.4 billion, and he couldn't turn a single one into cash. Even after the six months ran out, selling them was its own trap. Nobody buys 14.6 million shares at once. The second he started dumping that much stock, the price would slide before he finished, dragging his fortune down with it.
Here is what he did instead. He bought insurance on his own stock.
You can buy a contract that locks in a guaranteed price someone has to pay you for your shares later. Cuban locked his in at $85 each. From then on, no matter how far Yahoo fell, he could still sell at $85 and walk away with more than a billion dollars. The problem is that this kind of protection costs money, and insuring $1.4 billion is expensive.
He covered the cost in a strange way. He sold off his claim to Yahoo's biggest gains. He signed a second contract that said if the stock ever climbed past $205, someone else could buy his shares at that price and keep anything above it. He was betting it would never get there, and the money from that bet paid for his insurance almost exactly. The whole setup cost him nothing.
For a while, he looked like a fool. Yahoo kept climbing, blew past $205, and ran all the way to about $237. He had locked himself out of a fortune in gains, right at the top. Then the bubble burst. Yahoo went into freefall and crashed to roughly $13. Almost everyone holding it got wiped out. Cuban's $85 floor held the entire way down, and he walked off with his money still in his pocket.
The company that set all of this in motion never made it. Yahoo killed Broadcast .com in 2002, three years after paying $5.7 billion for it. Yahoo itself was sold off in 2017 for about $4.5 billion, less than it once paid for Cuban's company alone. Selling made him a billionaire on paper. The insurance trade is the only reason he kept it.
Part 2. Two college buddies built a website in 1995 just so they could listen to their old basketball team’s games from out of state. Three years later, it had the biggest opening day in stock market history, and it had never turned a single dollar of profit.
The two were Mark Cuban and his friend Todd Wagner. Both had gone to Indiana University, both were now stuck in Dallas, and neither could find a way to hear their college team play. So they built one. Cuban ran it out of the spare bedroom of his house with one computer server and a single internet line, living off the roughly $2 million he had made years earlier selling his first company. Plenty of people told him it was a stupid idea, that nobody would rig up a $4,000 computer to do the job of a $6 radio. As Cuban put it later, “People thought I was an idiot.”
They were just early. The site started streaming live audio in 1995, added video in 1997, and grew into the biggest place on the internet for live radio and online events. In 1998 they renamed it Broadcast .com and took it public.
On July 17, 1998, the stock was priced at $18 a share. By the time the first day of trading was over, it had closed near $63. The stock had more than tripled in a few hours, a 249% jump, and no company in the history of the American stock market had ever gained that much on its first day. On paper, Cuban’s slice of the company was suddenly worth around $300 million.
The business under that price had never made money. In all of 1997 it took in under $7 million in sales while losing more than $6 million, and its own official filing for the stock sale told investors in plain language to expect more losses for years. They bought it anyway, handing a money-losing project run out of a bedroom a price tag north of a billion dollars.
A spare-room hobby had turned Cuban into a paper multimillionaire, built almost entirely on hope about where the internet was headed. He had helped build one of the bubble’s brightest pieces with his own two hands, so he understood exactly how little was holding it up.
Toru Miyazaki gave 11 cats with advanced kidney disease an experimental injection. 15 others didn’t get it. A year later, 9 of the 11 treated cats were alive. Only 3 of the 15 untreated cats survived. He just filed for approval, and the drug fixes a defect only cats have.
Most cats die from one thing: their kidneys fail. By age 10, 4 in 10 cats already have chronic kidney disease, and by age 15, the rate doubles to 8 in 10. Once diagnosed, a cat has about 2 years left.
The reason kidney disease hits cats so hard is a broken protein in their blood. All mammals carry a protein that helps the kidneys clean out waste. In humans and dogs, the protein floats freely and goes to work when the kidneys are in trouble. In cats, it stays stuck to another protein and can’t get loose. So the waste piles up, and the kidneys eventually give out.
Miyazaki originally found the protein in 1999, back when he was at the University of Tokyo. He figured out the cat-specific glitch in 2015. The paper he published in the Veterinary Journal in February laid out the trial. The injection is a working version of the missing protein. His company, the Institute for AIM Medicine, filed the approval paperwork with Japan’s Ministry of Agriculture on April 24, 2026. If the review clears, the drug goes on sale in spring 2027.
The 30-year lifespan figure in the tweet is Miyazaki’s own projection of what cats could reach without kidney disease. The trial only ran a year, and the average cat today lives 15. Most die from the same disease this injection treats.
The research almost died in 2020. After running out of funding during COVID, Miyazaki went public. Cat owners across Japan responded by sending in 300 million yen, around 2 million dollars total. He resigned from the University of Tokyo and worked on the drug full time. The treatment in front of regulators today exists because cat lovers refused to let the research die.
Follow @anishmoonka for daily stories across science, history, psychology, culture & AI.
—————
Sources:
Clinical trial paper, Veterinary Journal, Tezuka et al. (Feb 2026): A clinical impact of apoptosis inhibitor of macrophage on feline chronic kidney disease sciencedirect.com/science/articl…
Part 2. Behind the cat drug story is a bigger study. Miyazaki tracked 423 patients starting dialysis and 563 more with chronic kidney disease. The same protein from the cat trial predicted who would survive longer in humans too. Human kidney disease is next in the pipeline.
In humans, the protein usually works. It floats freely in the blood and attaches to damaged kidney cells, signaling the immune system to remove them. The problem comes when the protein doesn't release from its parent antibody fast enough. The dialysis study found that patients with slow release had higher death rates and more cardiovascular trouble over time. Speed of release became a way to predict risk.
More than 800,000 Americans currently live with end-stage kidney disease, about 517,000 of them on dialysis. Each dialysis patient costs Medicare $87,000 to $110,000 per year. The US dialysis market hit $30.9 billion in 2025 and is projected to nearly double by 2034. Despite recent drug approvals, no treatment has been able to halt or reverse advanced kidney disease.
The cat drug came first for a specific reason. Cats have the simplest version of the problem: replace one broken protein with a working version, and the kidney repair process turns back on. In humans, the protein already works. The challenge there is timing and how to push it to release faster when needed.
In 2024 Miyazaki's lab worked with London's Francis Crick Institute to map the exact shape of how the protein binds to its parent antibody. The paper went into Nature Communications. Knowing the binding shape is what makes designing human treatments possible.
AIM research extends beyond kidneys. Miyazaki's lab has published on its role in autoimmune arthritis, stroke recovery, liver cancer, kidney stones, and glaucoma.
Manufacturing is being set up in Taiwan. The cat drug ships first because it's the cleanest test. Everything else in Miyazaki's pipeline depends on it working.
Take too much Ozempic, and your brain stops wanting things: food, sex, even the urge to get out of bed. People end up in hospital beds for days, staring at the ceiling, feeling nothing. The medical name for that state is anhedonia, and it tells you how the drug actually works.
Ozempic, Wegovy, and Mounjaro all belong to the same drug family, called GLP-1s. They kill hunger. They also quiet almost every other craving your brain produces.
Inside your brain there is a small region that makes a chemical called dopamine. Dopamine is your brain’s “this is worth wanting” chemical, the reason you reach for one more bite of pasta, refresh your inbox one more time, or pick up your phone every few minutes. GLP-1 drugs reach that region and turn the dopamine down. The right dose dampens the loudest craving first: food. Take too much, and the volume drops on everything else, sex, exercise, work, even the urge to get out of bed in the morning.
Anhedonia is the medical name for not feeling pleasure from anything at all. It looks identical to deep depression. The good news is that anhedonia from GLP-1s has an off switch: once the drug clears your system, the wanting comes back.
The FDA has logged over 1,150 reports of bad reactions tied to compounded GLP-1s through July 2025. These are custom-mixed versions made by smaller pharmacies. In many of those cases, patients accidentally took five to twenty times their prescribed dose. The cause is usually confusion between milliliters and units when measuring out a dose with an insulin syringe, since compounded versions come in plain vials instead of the pre-filled pens that brand-name Ozempic uses.
About 15 million Americans currently use a GLP-1, roughly one in eight adults. Around 75% of them eventually quit. Cost and side effects are the top reasons. A growing number describe a third reason that patients call “the lights dimming,” a flat, gray feeling across the whole day that doctors now recognize as anhedonia caused by the drug itself.
This same mechanism has caught pharma’s attention. Eli Lilly is now running two large clinical trials with a combined 2,200 patients to see if a GLP-1 drug can treat alcohol addiction. The bet is that the same brain switch that turns off cravings for food can also turn off cravings for alcohol, cocaine, nicotine, and gambling. A 2026 psychiatry review put it bluntly: doctors should be treating these as psychiatric drugs, because that is what they have turned out to be.
The drug works by quieting your brain’s signal that something is worth wanting. A normal dose turns the volume down on food cravings. Push the dose too high, and everything else goes quiet too.
Follow @anishmoonka for daily stories across science, history, psychology, culture & AI.
—————
Sources:
FDA alert on dosing errors with compounded GLP-1 drugs and 1,150+ adverse event reports through July 2025 fda.gov/drugs/postmark…
UIC Drug Information Group review of compounded semaglutide and tirzepatide overdoses showing patients took 5 to 20 times the prescribed dose dig.pharmacy.uic.edu/faqs/2025-2/ja…
National Consumers League update tracking 1,150 FDA adverse event reports for compounded GLP-1s as of July 31, 2025 nclnet.org/the-real-cost-…
Science Advances paper showing GLP-1 receptor activation reduces dopamine release in the brain’s reward circuit science.org/doi/10.1126/sc…
Osmind clinician analysis of GLP-1 drugs as psychiatric medication and Eli Lilly’s brenipatide Phase 3 trials for alcohol use disorder osmind.org/articles/glp-1…
KFF national poll showing about 1 in 8 U.S. adults currently use a GLP-1 drug, with cost and side effects as the top discontinuation reasons kff.org/health-costs/k…
GBC Health overview of 15 million GLP-1 users in the U.S. and the 75% discontinuation rate gbchealth.org/glp-1-drugs/
Part 2. Most people know Ozempic as a weight loss drug. The trial data is starting to look like weight loss is the side effect. In the largest study ever done on the drug, it cut heart attacks and strokes by 20%. And the protection kicked in before any weight came off.
That study was called SELECT. It tested semaglutide, the molecule in Ozempic and Wegovy, in 17,604 people with existing heart disease for about three and a half years. Alongside the 20% drop in major cardiac events, deaths from any cause fell 19% and heart failure events fell 18%. The FDA approved Wegovy for cardiovascular protection off the back of this single trial.
Then came FLOW, a separate kidney disease trial in 3,533 patients. It got stopped early because the results were too strong. Semaglutide cut the risk of kidney failure, kidney-related death, and major heart events by 24%, and deaths from any cause by 20%.
The same molecule keeps showing up in other organs. In a sleep apnea trial of nearly 500 obese patients, the related drug Zepbound cut breathing disruptions during sleep by 25 to 29 per hour. About half of the people on the highest dose were effectively cured of sleep apnea. The FDA approved that use in December 2024.
In a liver disease trial called ESSENCE, 63% of patients on semaglutide cleared the fatty inflammation that drives the worst form of liver disease, compared to 34% on placebo. The FDA approved Wegovy for that use last August.
GLP-1 drugs (the class that includes Ozempic, Wegovy, Mounjaro, and Zepbound) do a lot of things in the body at the same time. They lower blood pressure, drop inflammation markers in the blood, improve cholesterol numbers, and act directly on receptors built into the heart and blood vessels. That is why the drug seems to calm the underlying biology first, and the weight loss follows later.
Some cardiologists now compare this drug class to statins, the cholesterol drugs that became standard preventive medicine in the 1990s. Yale’s Harlan Krumholz has told reporters the cardiovascular benefit is “largely independent of the amount of weight loss achieved.” Global GLP-1 sales hit an annualized rate of around $25 billion by late 2023, already close to double what statins ever made at their peak.
Doctors running these trials are starting to describe Ozempic as a heart and metabolic protection drug that happens to cause weight loss as a side effect. If these numbers hold up in everyday practice, this might end up being the most important class of drugs since statins.